DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
02 Oct 2024
// PRESS RELEASE
01 Oct 2024
// FDA
30 Sep 2024
// INDPHARMAPOST
01 1ATORVA STATN CALCIUM HYDRATE
02 1ATORVASTATIN CALCIUM TRIHYDRATE FORM-1
03 1Abiraterone Acetate
04 1Amlodipine besylate
05 1Atorvastatin Calcium Hydrate
06 1Azacitidine
07 1CETIRIZINE DIHYDROCHLORIDE EP
08 1CLOPIDOGREL SULFATE FORM-I
09 1CLOPIDOGREL SULPHATE FORM-II
10 1Capecitabine
11 1Dasatinib Monohydrate
12 1FINASTERIDE Form-Ⅲ
13 1Fexofenadine Hydrochloride
14 1GEMCITABINE HYDROCHLORIDE
15 1Lenalidomide
16 1Levetiracetam
17 1Losartan Potassium
18 1Losartan potassium
19 1NIZATIDINE
20 1Naproxen
21 1Naratriptan Hydrochloride
22 2Ondansetron hydrochloride hydrate
23 1Pioglitazone Hydrochloride
24 1RISPERIDONE FORM-Ⅰ
25 1Rabeprazole Sodium
26 1Rivaroxaban
27 1SUGAM MADEX SODIUM
28 2Valsartan
01 2Dr. Reddy's Laboratories Limited office and manufacturing site in Mexico
02 28Dr. Reddy's Laboratories Ltd.
01 30India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registration Number : 303MF10054
Registrant's Address : Km. 4.5 Carretera Federal Cuernavaca-Cuautla 62578 Jiutepec, Morelos, Mexico
Initial Date of Registration : 2021-03-30
Latest Date of Registration : 2021-03-30
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Registration Number : 219MF10352
Registrant's Address : 8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA
Initial Date of Registration : 2007-12-10
Latest Date of Registration : 2009-10-13